CloudCuddle provides mobile and safe sleeping environment for disabled children

Inflazome provides targeted therapies for inflammatory diseases

Corsair FEAM: Better Protection from Impact Injury

Umoove allows mobile a face and eye tracking

Umoove, a Jerusalem-based spinoff, created a face and eye-tracking solution that is compatible with any smartphone or tablet with a front-facing camera. The company's core technology does not require any additional hardware of any kind. Furthermore, the developed in-house medical application is also powering eye tracking research in top universities across the world. Eye tracking and digital biomarkers are used as a method for diagnosis and therapy of many neurological disorders such as Attention deficit hyperactivity disorder (ADHD), concussions, traumatic brain injury, Alzheimer's disease (lat. morbus Alzheimerianus), autism (lat. Autismus), strokes (lat. Apoplexia), amyotrophic lateral sclerosis (amyotrophic lateralibus lumbos) and more. The company's first product, uHealth, was released in 2015. 


Beats Medical - a technology solution for people with Parkinson's disease

Beats Medical is a pioneering medical spinoff, which was founded by Dr  Ciara Clancy in 2012. The company is intended to revolutionize how people with Parkinson's are treated, assessed, and monitored. Their award-winning solution provides exercises based on allied health therapies for mobility, speech and dexterity symptoms. Beats Medical smartphone application and hardware solution help reduce treatment costs, improve mobility, and increase significantly the quality of life of a person with Parkinson's (lat. Parkinson scriptor morbus) using digital biomarkers and metronome treatment.


Global Kinetics provides a continuous assessment of movement disorder symptoms

Global Kinetics Pty Ltd. is committed to improving the lives of those with Parkinson's disease with advanced medical technologies. The company was formed in order to commercialise its lead product, the Personal KinetiGraph™ (PKG™), also known as the Parkinson's KinetiGraph™ outside the USA. Developed in conjunction with the world-renowned Florey Institute of Neuroscience & Mental Health in Melbourne, Australia, the PKG enables the precise monitoring, quantification, and reporting of movement symptoms in Parkinson's. To date, Global Kinetics has supported clinical decisions for doctors who treat patients with Parkinson's disease across 17 countries with more than 3,000,000 hours of clinical data from our FDA-cleared, CE-marked PKG wearable device. Global Kinetics, a privately held company, is headquartered in Melbourne, Australia with offices in London, UK, Minneapolis, MN, and Portsmouth, NH, USA.


Breakthrough treatments for CNS Diseases

Heliex Power: harnessing the power of steam

SchoolScreener provides vision, hearing and BMI screening

PostopQRS provides an objective assessment of post-operative recovery

Quality of recovery following surgery and anaesthesia is of vital importance to improving patient outcome & clinical practice. The Post-operative Quality of Recovery Scale (PostopQRS) is a measurement tool to assess multiple domains of post-operative recovery over time. It was developed by the independent Scientific Advisory Board. PostopQRS is comprised of a number of questions that objectively measure patient recovery, which are clustered into five different domains (physiological, emotive, nociceptive, activities of daily living, and cognitive) and one self-assessment domain. It has been designed to measure recovery over multiple time periods. The target use for the PostopQRS research and audit of practice.


An advanced material that can sense impacts or pressure

XOnano Smartfoam (BYU technology) comes in either an Impact sensing or a Pressure sensing variant. The impact measuring material requires no supply voltage to work, the foam sensor itself generates a voltage when impacted. The pressure sensing material, however, does require a small voltage generating device to measure the change in internal resistance. XOnano Impact Sensing Smartfoam has been demonstrated to provide critical impact data and protection in many different products. XOnano has partnered with Rogers Corporation to provide sensing foam capabilities to their Poron and XRD product lines. These foams provide industry-leading energy absorption while XOnano’s Smartfoam technology enables them to sense the impacts.


Consumer-oriented software apps to improve near vision sharpness

GlassesOff is a non-invasive product helping people suffering from Presbyopia to improve their near vision. Presbyopia, commonly referred to as 'aging eye', is the inevitable condition related to hardening of the crystalline lens inside the eye that affects most people by the age of 40 and practically everyone by the age of 51, making it difficult to see near objects clearly (for example, reading) without the aid of reading glasses. GlassesOff is based on leading-edge scientific breakthroughs in the area of eye-brain dysfunctionalities.


Cookies help us deliver our Services. By using our website or clicking I agree, you agree to our use of cookies. Learn more about our cookie and privacy policy.